Wird geladen...
Buprenorphine dosing for the treatment of opioid use disorder through pregnancy and postpartum
PURPOSE OF REVIEW: Opioid-related deaths are a leading cause of mortality during pregnancy through 12 months postpartum. Buprenorphine use during pregnancy is increasing, yet expert opinion on its dosing through the perinatal period is limited. We provide a review of the current clinical literature...
Gespeichert in:
| Veröffentlicht in: | Curr Treat Options Psychiatry |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880143/ https://ncbi.nlm.nih.gov/pubmed/33585165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40501-020-00221-z |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|